Macérat glycériné de bourgeons de Myrtillier
Food supplement declared in France, decision dated 25 November 2024
Macérat glycériné de bourgeons de Myrtillier (La réserve de l'écureuil) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium myrtillus 225 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- La réserve de l'écureuil
- Food business operator placing the product on the market
- Colonges Kelly
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- entre 2 à 10 gouttes jusqu'à 3 fois par jour
- Intended populations
- General population
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant, Eye / Vision
Declaration 1573, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium myrtillus L. | Bourgeon | Macérât hydroglycériné | 225 mg |
Additives
E422
Other ingredients
Alcool éthylique
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Macérat glycériné de bourgeons de myrtillier Clémentine Benoit EI, declared in 2025 : different composition: 2 ingredient(s) added, 1 missing
- Macérat glycériné de bourgeons de Myrtillier EI Marie Laresche, declared in 2024 : different composition: 1 ingredient(s) added, 0 missing
Brand : La réserve de l'écureuil
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Macérat glycériné de bourgeons de Myrtillier (La réserve de l'écureuil): composition and regulation”, https://compoatlas.com/en/supplements/products/1573-macerat-glycerine-de-bourgeons-de-myrtillier, updated 15 November 2026.